Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community
Control of infection classically involves hand and healthcare hygiene, reduction of selective and ineffective chemotherapy, reduction of invasive procedures and achlorhydria and adequate staffing, along with appropriate containment and concentration of patients. Investigation and control of any cont...
Gespeichert in:
Veröffentlicht in: | Clinical microbiology and infection 2008-01, Vol.14, p.124-133 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 133 |
---|---|
container_issue | |
container_start_page | 124 |
container_title | Clinical microbiology and infection |
container_volume | 14 |
creator | Warren, R.E. Harvey, G. Carr, R. Ward, D. Doroshenko, A. |
description | Control of infection classically involves hand and healthcare hygiene, reduction of selective and ineffective chemotherapy, reduction of invasive procedures and achlorhydria and adequate staffing, along with appropriate containment and concentration of patients. Investigation and control of any continuing sources of infection in food and water supplies is important also, as is recognition of individuals carrying high-risk strains and species. The onset of infection may be distant from the time of acquisition and may critically affect epidemiological assessment of control points. Carriage may be prolonged, increasing the likelihood of recurrent infection and exacerbating the difficulty of control. Mortality associated with resistance is difficult to assess retrospectively and may not be high, complicating analysis of the success or failure of control measures. |
doi_str_mv | 10.1111/j.1469-0691.2007.01870.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70163839</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1198743X14604833</els_id><sourcerecordid>70163839</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4760-969ef981d89a43020cbd980ab1c5508fb11d0651b432a36067201d029e8c576b3</originalsourceid><addsrcrecordid>eNqNkU2O1DAQhSPEiBkGroC8YpdQjhPHXrCAFn9So9mAxM5y7MqMW4nd2Al0X4uDcKZx6BYsGW9ccr33qvS5KAiFiubzalfRhssSuKRVDdBVQEUH1eFRcfW38TjXVIqya9i3y-JpSjsAqBlrnhSXVNC2aRm_Kvwm-DmGkYSBOD-gmV3widgFyRwIHmb0Fm2Z9rkTl4n8_lWO2sx60gnLfQx2Mc7fkhBvtXdpSjmE3IW0d7MeE9HekvkOiQnTtHg3H58VF0Nu4PPzfV18ff_uy-Zjub358GnzZluapuNQSi5xkIJaIXXDoAbTWylA99S0LYihp9QCb2nfsFozDryrIb_UEoVpO96z6-LlKTev-H3BNKvJJYPjqD2GJakOKGeCySwUJ6GJIaWIg9pHN-l4VBTUylrt1IpUrUjVylr9Ya0O2friPGPpJ7T_jGe4WfD6JPjpRjw-OFhttp_XKvvfnvyYSf1wGFUyDr1B62L-DmWD-_-W99vBpGY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70163839</pqid></control><display><type>article</type><title>Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Warren, R.E. ; Harvey, G. ; Carr, R. ; Ward, D. ; Doroshenko, A.</creator><creatorcontrib>Warren, R.E. ; Harvey, G. ; Carr, R. ; Ward, D. ; Doroshenko, A.</creatorcontrib><description>Control of infection classically involves hand and healthcare hygiene, reduction of selective and ineffective chemotherapy, reduction of invasive procedures and achlorhydria and adequate staffing, along with appropriate containment and concentration of patients. Investigation and control of any continuing sources of infection in food and water supplies is important also, as is recognition of individuals carrying high-risk strains and species. The onset of infection may be distant from the time of acquisition and may critically affect epidemiological assessment of control points. Carriage may be prolonged, increasing the likelihood of recurrent infection and exacerbating the difficulty of control. Mortality associated with resistance is difficult to assess retrospectively and may not be high, complicating analysis of the success or failure of control measures.</description><identifier>ISSN: 1198-743X</identifier><identifier>EISSN: 1469-0691</identifier><identifier>DOI: 10.1111/j.1469-0691.2007.01870.x</identifier><identifier>PMID: 18154536</identifier><language>eng</language><publisher>Oxford, UK: Elsevier Ltd</publisher><subject>Animals ; Anti-Bacterial Agents - pharmacology ; Bacteremia - epidemiology ; Bacteremia - microbiology ; Bacteremia - prevention & control ; beta-Lactamases - biosynthesis ; Carriage ; Carrier State - microbiology ; Community-Acquired Infections - epidemiology ; Community-Acquired Infections - microbiology ; Community-Acquired Infections - prevention & control ; control ; Cross Infection - epidemiology ; Cross Infection - microbiology ; Cross Infection - prevention & control ; Drug Resistance, Multiple, Bacterial ; E. coli ; Escherichia coli - drug effects ; Escherichia coli - enzymology ; Escherichia coli Infections - epidemiology ; Escherichia coli Infections - microbiology ; Escherichia coli Infections - prevention & control ; extended-spectrum β-lactamases ; Humans ; Infection Control - methods ; review ; United Kingdom - epidemiology ; urinary infection ; Urinary Tract Infections - epidemiology ; Urinary Tract Infections - microbiology ; Urinary Tract Infections - prevention & control</subject><ispartof>Clinical microbiology and infection, 2008-01, Vol.14, p.124-133</ispartof><rights>2008 European Society of Clinical Infectious Diseases</rights><rights>2008 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4760-969ef981d89a43020cbd980ab1c5508fb11d0651b432a36067201d029e8c576b3</citedby><cites>FETCH-LOGICAL-c4760-969ef981d89a43020cbd980ab1c5508fb11d0651b432a36067201d029e8c576b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1469-0691.2007.01870.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1469-0691.2007.01870.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18154536$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Warren, R.E.</creatorcontrib><creatorcontrib>Harvey, G.</creatorcontrib><creatorcontrib>Carr, R.</creatorcontrib><creatorcontrib>Ward, D.</creatorcontrib><creatorcontrib>Doroshenko, A.</creatorcontrib><title>Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community</title><title>Clinical microbiology and infection</title><addtitle>Clin Microbiol Infect</addtitle><description>Control of infection classically involves hand and healthcare hygiene, reduction of selective and ineffective chemotherapy, reduction of invasive procedures and achlorhydria and adequate staffing, along with appropriate containment and concentration of patients. Investigation and control of any continuing sources of infection in food and water supplies is important also, as is recognition of individuals carrying high-risk strains and species. The onset of infection may be distant from the time of acquisition and may critically affect epidemiological assessment of control points. Carriage may be prolonged, increasing the likelihood of recurrent infection and exacerbating the difficulty of control. Mortality associated with resistance is difficult to assess retrospectively and may not be high, complicating analysis of the success or failure of control measures.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Bacteremia - epidemiology</subject><subject>Bacteremia - microbiology</subject><subject>Bacteremia - prevention & control</subject><subject>beta-Lactamases - biosynthesis</subject><subject>Carriage</subject><subject>Carrier State - microbiology</subject><subject>Community-Acquired Infections - epidemiology</subject><subject>Community-Acquired Infections - microbiology</subject><subject>Community-Acquired Infections - prevention & control</subject><subject>control</subject><subject>Cross Infection - epidemiology</subject><subject>Cross Infection - microbiology</subject><subject>Cross Infection - prevention & control</subject><subject>Drug Resistance, Multiple, Bacterial</subject><subject>E. coli</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli - enzymology</subject><subject>Escherichia coli Infections - epidemiology</subject><subject>Escherichia coli Infections - microbiology</subject><subject>Escherichia coli Infections - prevention & control</subject><subject>extended-spectrum β-lactamases</subject><subject>Humans</subject><subject>Infection Control - methods</subject><subject>review</subject><subject>United Kingdom - epidemiology</subject><subject>urinary infection</subject><subject>Urinary Tract Infections - epidemiology</subject><subject>Urinary Tract Infections - microbiology</subject><subject>Urinary Tract Infections - prevention & control</subject><issn>1198-743X</issn><issn>1469-0691</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU2O1DAQhSPEiBkGroC8YpdQjhPHXrCAFn9So9mAxM5y7MqMW4nd2Al0X4uDcKZx6BYsGW9ccr33qvS5KAiFiubzalfRhssSuKRVDdBVQEUH1eFRcfW38TjXVIqya9i3y-JpSjsAqBlrnhSXVNC2aRm_Kvwm-DmGkYSBOD-gmV3widgFyRwIHmb0Fm2Z9rkTl4n8_lWO2sx60gnLfQx2Mc7fkhBvtXdpSjmE3IW0d7MeE9HekvkOiQnTtHg3H58VF0Nu4PPzfV18ff_uy-Zjub358GnzZluapuNQSi5xkIJaIXXDoAbTWylA99S0LYihp9QCb2nfsFozDryrIb_UEoVpO96z6-LlKTev-H3BNKvJJYPjqD2GJakOKGeCySwUJ6GJIaWIg9pHN-l4VBTUylrt1IpUrUjVylr9Ya0O2friPGPpJ7T_jGe4WfD6JPjpRjw-OFhttp_XKvvfnvyYSf1wGFUyDr1B62L-DmWD-_-W99vBpGY</recordid><startdate>200801</startdate><enddate>200801</enddate><creator>Warren, R.E.</creator><creator>Harvey, G.</creator><creator>Carr, R.</creator><creator>Ward, D.</creator><creator>Doroshenko, A.</creator><general>Elsevier Ltd</general><general>Blackwell Publishing Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200801</creationdate><title>Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community</title><author>Warren, R.E. ; Harvey, G. ; Carr, R. ; Ward, D. ; Doroshenko, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4760-969ef981d89a43020cbd980ab1c5508fb11d0651b432a36067201d029e8c576b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Bacteremia - epidemiology</topic><topic>Bacteremia - microbiology</topic><topic>Bacteremia - prevention & control</topic><topic>beta-Lactamases - biosynthesis</topic><topic>Carriage</topic><topic>Carrier State - microbiology</topic><topic>Community-Acquired Infections - epidemiology</topic><topic>Community-Acquired Infections - microbiology</topic><topic>Community-Acquired Infections - prevention & control</topic><topic>control</topic><topic>Cross Infection - epidemiology</topic><topic>Cross Infection - microbiology</topic><topic>Cross Infection - prevention & control</topic><topic>Drug Resistance, Multiple, Bacterial</topic><topic>E. coli</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli - enzymology</topic><topic>Escherichia coli Infections - epidemiology</topic><topic>Escherichia coli Infections - microbiology</topic><topic>Escherichia coli Infections - prevention & control</topic><topic>extended-spectrum β-lactamases</topic><topic>Humans</topic><topic>Infection Control - methods</topic><topic>review</topic><topic>United Kingdom - epidemiology</topic><topic>urinary infection</topic><topic>Urinary Tract Infections - epidemiology</topic><topic>Urinary Tract Infections - microbiology</topic><topic>Urinary Tract Infections - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Warren, R.E.</creatorcontrib><creatorcontrib>Harvey, G.</creatorcontrib><creatorcontrib>Carr, R.</creatorcontrib><creatorcontrib>Ward, D.</creatorcontrib><creatorcontrib>Doroshenko, A.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical microbiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Warren, R.E.</au><au>Harvey, G.</au><au>Carr, R.</au><au>Ward, D.</au><au>Doroshenko, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community</atitle><jtitle>Clinical microbiology and infection</jtitle><addtitle>Clin Microbiol Infect</addtitle><date>2008-01</date><risdate>2008</risdate><volume>14</volume><spage>124</spage><epage>133</epage><pages>124-133</pages><issn>1198-743X</issn><eissn>1469-0691</eissn><abstract>Control of infection classically involves hand and healthcare hygiene, reduction of selective and ineffective chemotherapy, reduction of invasive procedures and achlorhydria and adequate staffing, along with appropriate containment and concentration of patients. Investigation and control of any continuing sources of infection in food and water supplies is important also, as is recognition of individuals carrying high-risk strains and species. The onset of infection may be distant from the time of acquisition and may critically affect epidemiological assessment of control points. Carriage may be prolonged, increasing the likelihood of recurrent infection and exacerbating the difficulty of control. Mortality associated with resistance is difficult to assess retrospectively and may not be high, complicating analysis of the success or failure of control measures.</abstract><cop>Oxford, UK</cop><pub>Elsevier Ltd</pub><pmid>18154536</pmid><doi>10.1111/j.1469-0691.2007.01870.x</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1198-743X |
ispartof | Clinical microbiology and infection, 2008-01, Vol.14, p.124-133 |
issn | 1198-743X 1469-0691 |
language | eng |
recordid | cdi_proquest_miscellaneous_70163839 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Animals Anti-Bacterial Agents - pharmacology Bacteremia - epidemiology Bacteremia - microbiology Bacteremia - prevention & control beta-Lactamases - biosynthesis Carriage Carrier State - microbiology Community-Acquired Infections - epidemiology Community-Acquired Infections - microbiology Community-Acquired Infections - prevention & control control Cross Infection - epidemiology Cross Infection - microbiology Cross Infection - prevention & control Drug Resistance, Multiple, Bacterial E. coli Escherichia coli - drug effects Escherichia coli - enzymology Escherichia coli Infections - epidemiology Escherichia coli Infections - microbiology Escherichia coli Infections - prevention & control extended-spectrum β-lactamases Humans Infection Control - methods review United Kingdom - epidemiology urinary infection Urinary Tract Infections - epidemiology Urinary Tract Infections - microbiology Urinary Tract Infections - prevention & control |
title | Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T01%3A00%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Control%20of%20infections%20due%20to%20extended-spectrum%20%CE%B2-lactamase-producing%20organisms%20in%20hospitals%20and%20the%20community&rft.jtitle=Clinical%20microbiology%20and%20infection&rft.au=Warren,%20R.E.&rft.date=2008-01&rft.volume=14&rft.spage=124&rft.epage=133&rft.pages=124-133&rft.issn=1198-743X&rft.eissn=1469-0691&rft_id=info:doi/10.1111/j.1469-0691.2007.01870.x&rft_dat=%3Cproquest_cross%3E70163839%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70163839&rft_id=info:pmid/18154536&rft_els_id=S1198743X14604833&rfr_iscdi=true |